Skip to content

Clinical trials

Phase 3 Shock, Septic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Shock, Septic Phase: Phase 3 Country / region: United States Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20061
20081
20091
20171
20182
20192
20201
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting2
Terminated2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Virginia2
Children's Hospital of Philadelphia1
Eisai Inc.1
Eli Lilly and Company1
Jerry Zimmerman1
Massachusetts General Hospital1
National Institute of General Medical Sciences (NIGMS)1
New York Presbyterian Brooklyn Methodist Hospital1
Rush University Medical Center1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Shock, Septic12
Sepsis8
Hypovolemia1
Respiratory Insufficiency1
Shock1
Systemic Inflammatory Response Syndrome1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.